Literature DB >> 31309295

Characteristics and risk factors of an emergency department visit in patients with systemic lupus erythematosus.

Yoshiki Nagai1, Naoto Yokogawa2, Kota Shimada2, Shoji Sugii2.   

Abstract

This study aimed to examine the characteristics of patients with systemic lupus erythematosus (SLE) visiting the emergency department (ED) and the risk factors of an ED visit by these patients. This 4-year retrospective study was performed at a tertiary care center in Japan. We included all 205 patients with SLE who were treated in our outpatient clinic between April 1, 2008 and March 31, 2012 and divided them into two groups: those who visited the ED (the ED-user group) and those who did not (the ED-non-user group). We statistically compared the patient backgrounds and characteristics of the groups and identified the risk factors of an ED visit. Of all the patients, 118 visited the ED during study period and 87 did not. In total, 269 events were identified in the ED-user group. Of these, 91 (33.8%) were cases of infection, 32 (11.9%) were orthopedic problems, 32 (11.9%) were cases of gastrointestinal disease, 31 (11.5%) were cases of neurological disease, and 25 (9.3%) were cardiovascular events. Twenty-four events (8.9%) were due to SLE flares, of which ten (41.7%) were cases of neuropsychiatric lupus (NPSLE). The glucocorticoid dosage and the presence of a psychiatric illness, NPSLE, and lupus nephritis were higher among the ED-user group. Multivariate logistic regression analysis demonstrated high glucocorticoid dosage to be a risk factor of an ED visit. Among SLE patients, infections were the principal reason for visiting the ED. The most common reasons for an ED visit were common diseases rather than flares.

Entities:  

Keywords:  Emergency department; Flare; Infection; Rheumatologic emergency; Systemic lupus erythematosus (SLE)

Mesh:

Substances:

Year:  2019        PMID: 31309295     DOI: 10.1007/s00296-019-04377-7

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  27 in total

1.  Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus.

Authors:  R Cervera; M A Khamashta; J Font; G D Sebastiani; A Gil; P Lavilla; A O Aydintug; A Jedryka-Góral; E de Ramón; A Fernández-Nebro; M Galeazzi; H J Haga; A Mathieu; F Houssiau; G Ruiz-Irastorza; M Ingelmo; G R Hughes
Journal:  Medicine (Baltimore)       Date:  1999-05       Impact factor: 1.889

2.  Frequent use of the emergency department among persons with systemic lupus erythematosus.

Authors:  Pantelis Panopalis; Joann Zell Gillis; Jinoos Yazdany; Laura Trupin; Aimee Hersh; Laura Julian; Lindsey A Criswell; Patricia Katz; Edward Yelin
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-03       Impact factor: 4.794

Review 3.  Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature.

Authors:  B Kovacs; T L Lafferty; L H Brent; R J DeHoratius
Journal:  Ann Rheum Dis       Date:  2000-02       Impact factor: 19.103

Review 4.  The emergency room in systemic rheumatic diseases.

Authors:  G Slobodin; A Hussein; M Rozenbaum; I Rosner
Journal:  Emerg Med J       Date:  2006-09       Impact factor: 2.740

5.  Risk factors and prognostic influence of infection in a single cohort of 87 adults with systemic lupus erythematosus.

Authors:  V Noël; O Lortholary; P Casassus; P Cohen; T Généreau; M H André; L Mouthon; L Guillevin
Journal:  Ann Rheum Dis       Date:  2001-12       Impact factor: 19.103

6.  Lupus patients in an emergency unit. Causes of consultation, hospitalization and outcome. A cohort study.

Authors:  J Rojas-Serrano; M H Cardiel
Journal:  Lupus       Date:  2000       Impact factor: 2.911

7.  Systemic lupus erythematosus disease activity index 2000.

Authors:  Dafna D Gladman; Dominique Ibañez; Murray B Urowitz
Journal:  J Rheumatol       Date:  2002-02       Impact factor: 4.666

8.  A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus.

Authors: 
Journal:  N Engl J Med       Date:  1991-01-17       Impact factor: 91.245

9.  Serious infections in British patients with systemic lupus erythematosus: hospitalisations and mortality.

Authors:  F Goldblatt; S Chambers; A Rahman; D A Isenberg
Journal:  Lupus       Date:  2009-07       Impact factor: 2.911

10.  Predictors of major infections in systemic lupus erythematosus.

Authors:  Guillermo Ruiz-Irastorza; Nerea Olivares; Ioana Ruiz-Arruza; Agustin Martinez-Berriotxoa; Maria-Victoria Egurbide; Ciriaco Aguirre
Journal:  Arthritis Res Ther       Date:  2009-07-15       Impact factor: 5.156

View more
  1 in total

1.  Performance of Procalcitonin to Distinguish Fungal from Bacterial Infections in Patients with Systemic Lupus Erythematosus.

Authors:  Shuangjun He; Jun Ma; Chenyu Fan; Chao Tang; Yi Chen; Cuiying Xie
Journal:  Infect Drug Resist       Date:  2021-11-16       Impact factor: 4.003

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.